STOCK TITAN

Zodiac Partners offers $0.84 per share to buy Destination XL (NASDAQ: DXLG)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SC TO-T/A

Rhea-AI Filing Summary

Camac Fund and acquisition vehicle Zodiac Partners II, LLC filed Amendment No. 4 to a Schedule TO offering to purchase all outstanding shares of Destination XL Group, Inc. at $0.84 per share in cash. The amendment incorporates an Amended Offer to Purchase, an amended Letter of Transmittal and related exhibits, and references an Equity Commitment Letter and an indicative $75 million revolving credit facility term sheet. The Offer remains subject to the terms, conditions and procedures set forth in the Offer to Purchase and accompanying documents.

Positive

  • None.

Negative

  • None.

Insights

Amendment consolidates offer documents and funding exhibits.

The amendment attaches an Amended Offer to Purchase, amended Letter of Transmittal and an Equity Commitment Letter, and cites a confidential $75 million revolving credit facility term sheet. These exhibits document the purchaser's financing and distribution mechanics for the cash tender.

Legal contingencies such as the Offer's conditions and any regulatory or statutory approval references appear in the incorporated sections; timing and consummation remain governed by the Offer to Purchase language.

Price and financing references signal a financed cash tender at $0.84 per share.

The filing specifies the cash consideration of $0.84 per Share and cites an Equity Commitment Letter plus an indicative $75 million revolver term sheet as funding sources. These items indicate planned committed equity plus potential credit support referenced in exhibits.

Whether financing conditions or lender covenants could affect closing depends on terms in the referenced commitments and the Offer's stated conditions; the amendment centralizes those references for holders to review.

Offer price $0.84 per Share cash tender offer per Amended Offer to Purchase
Indicative revolver $75 million indicative Revolving Credit Facility Term Sheet (exhibit)
Filing date June 23, 2026 date of Amendment No. 4 and amended exhibits
Offer to Purchase regulatory
"Amended Offer to Purchase, dated June 23, 2026"
An offer to purchase is a formal proposal from one party to buy a specific amount of shares or assets from another party at a set price. It matters to investors because it signals interest in acquiring ownership and can influence the value or control of a company. Think of it as someone putting forward a clear, serious offer to buy something they find valuable.
Letter of Transmittal financial
"Amended Form of Letter of Transmittal attached as exhibit"
A letter of transmittal is a written form investors use when sending physical stock certificates or electronic ownership documents to a company or its agent to surrender shares, tender them in an offer, or claim payment or replacement securities. It acts like a packing slip that lists what is enclosed, gives instructions on how the transfer should be handled, and provides proof of the transaction—important for ensuring investors receive the correct payment or new securities without delay or dispute.
Equity Commitment Letter financial
"Equity Commitment Letter between Zodiac Partners II, LLC and Camac Fund LP"
A written promise from an investor or group to provide a specified amount of capital for a deal, such as an acquisition or a new financing round. It matters to investors because it shows how likely a transaction is to close and how much fresh money will be available, similar to a down-payment commitment when buying a house: the stronger the promise, the less risk that the deal will fall apart or that existing shareholders will face unexpected dilution.
Guaranteed Delivery regulatory
"Amended Notice of Guaranteed Delivery"
Guaranteed delivery is a promise in securities transactions that a buyer or seller will receive the agreed shares or cash even if paperwork, payment, or regulatory clearances are not completed at the moment the deal is announced. Think of it as a short-term IOU that lets a trade settle on schedule while the missing pieces are finalized; for investors it reduces the risk of a failed transaction and keeps offerings or block trades from being delayed or canceled.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What price is Zodiac Partners II offering for DXLG shares?

The offer price is $0.84 per share in cash. This cash consideration is stated in the Amended Offer to Purchase incorporated into the amendment.

Who is making the tender offer for DXLG?

The offeror is Zodiac Partners II, LLC, an acquisition entity of Camac Fund, LP. Both parties are listed as filing persons in the Schedule TO amendment.

How is the tender offer funded according to the filing?

The filing references an Equity Commitment Letter and an indicative $75 million revolving credit facility term sheet as exhibits, indicating committed equity plus credit arrangements as funding sources.

What documents were attached to Amendment No. 4?

Amendment No. 4 attaches an Amended Offer to Purchase, amended Letter of Transmittal, amended guaranteed delivery notice, amended equity commitment letters, press releases, and a filing fee exhibit.

Does the amendment change the offer terms or conditions?

The amendment incorporates an Amended Offer to Purchase and related exhibits; specific changes to terms or conditions, if any, are reflected in that Amended Offer to Purchase and its sections cited in the filing.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

AMENDMENT NO. 4 TO

SCHEDULE TO

 

Tender Offer Statement Under Section 14(d)(1) or 13(e)(1)

of the Securities Exchange Act of 1934

 

Destination XL Group, Inc.

(Name of Subject Company)

 

Zodiac Partners II, LLC

(Name of Filing Person (Offeror))

 

Camac Fund, LP

(Name of Filing Person (Parent of Offeror))

 

Common Stock, par value $0.01 per share

(Title of Class of Securities)

 

25065K104

(CUSIP Number of Class of Securities)

 

Craig Rosmarin

Chief Financial Officer

1601-1 N Main St #3159, SMB#92283, Jacksonville, FL 32206

(917) 692-1844

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on

Behalf of Filing Persons)

 

Copies to:

Donald R. Reynolds

Wyrick Robbins Yates & Ponton LLP

4101 Lake Boone Trail, Suite 300

Raleigh, NC 27607

(919) 781-4000

 

 ☐ Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
   
Check the appropriate boxes below to designate any transactions to which the statement relates:
 
  third-party tender offer subject to Rule 14d-1.
     
  issuer tender offer subject to Rule 13e-4.
     
  going-private transaction subject to Rule 13e-3.
     
  amendment to Schedule 13D under Rule 13d-2.
     
Check the following box if the filing is a final amendment reporting the results of the tender offer.  ☐
 
If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:
 
  Rule 13e-4(i) (Cross-Border Issuer Tender Offer)
     
  Rule 14d-1(d) (Cross-Border Third-Party Tender Offer)

 

 

 

 

 

 

This Amendment No. 4 to Tender Offer Statement on Schedule TO (this “Schedule TO”) is filed by Camac Fund, LP, a Delaware limited partnership (“Camac Fund”), and Zodiac Partners II, LLC, a Delaware limited liability company (the “Purchaser”, “Zodiac Partners II, LLC”) and an acquisition entity of Camac Fund. This Schedule TO relates to the offer by the Purchaser to purchase all outstanding shares of common stock, par value $0.01 per share (the “Shares”), of Destination XL Group, Inc., a Delaware corporation (“DXL”), at $0.84 per Share, to the seller in cash, without interest and less any required withholding taxes, upon the terms and subject to the conditions set forth in the Offer to Purchase, originally dated May 12, 2026 (the “Offer to Purchase”), and in the accompanying Letter of Transmittal, copies of which are attached hereto as Exhibits (a)(1)(A) and (a)(1)(B), respectively, which, together with any amendments or supplements thereto, collectively constitute the “Offer”.

 

Item 1. Summary Term Sheet.

 

The information set forth in the Offer to Purchase under the caption SUMMARY TERM SHEET is incorporated herein by reference.

 

Item 2. Subject Company Information.

 

(a) The name, address, and telephone number of the subject company’s principal executive offices are as follows:

 

Destination XL Group, Inc.

555 Turnpike Street

Canton, MA 02021

 

(b) This Schedule TO relates to the Offer by the Purchaser to purchase all of the issued and outstanding Shares. According to DXL’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 19, 2026 (the “DXL FY2025 Form 10-K”), as of March 9, 2026 there were 54,810,511 Shares issued and outstanding, and based on the Purchaser’s review of the DXL FY2025 Form 10-K, we believe as of January 31, 2026, there were approximately 44,000 stock options to purchase Shares, and 1,259,000 restricted stock units outstanding.

 

(c) The information set forth under the caption THE OFFER - Section 6 (“Price Range of Shares; Dividends”) and Section 11 (“Background of the Offer”) of the Offer to Purchase is incorporated herein by reference.

 

Item 3. Identity and Background of Filing Person.

 

(a)-(c) The filing companies of this Schedule TO are (i) Camac Fund LP, and (ii) the Purchaser, Zodiac Partners II, LLC. The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

THE OFFER - Section 9 (“Certain Information Concerning the Purchaser, Zodiac Partners II, LLC, and Camac Fund, LP”) and Schedule I attached thereto.

 

 

 

 

Item 4. Terms of the Transaction.

 

(a)(1)(i)-(viii), (x), (xii), (a)(2) The information set forth in the Offer to Purchase is incorporated herein by reference.

 

Subsections (a)(1)(ix) and (xi) are not applicable.

 

Item 5. Past Contacts, Transactions, Negotiations and Agreements.

 

(a), (b) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

INTRODUCTION

 

THE OFFER - Section 9 (“Certain Information Concerning the Purchaser, Zodiac Partners II, LLC, and Camac Fund, LP”) and Schedule I attached thereto

 

THE OFFER - Section 10 (“Source and Amount of Funds”) and Schedule I attached thereto

 

THE OFFER - Section 11 (“Background of the Offer”)

 

THE OFFER - Section 12 (“Purpose of the Offer and the Proposed Merger; Plans for DXL; Statutory Requirements; Approval of the Proposed Merger”)

 

Item 6. Purposes of the Transaction and Plans or Proposals.

 

(a) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

INTRODUCTION

 

THE OFFER - Section 12 (“Purpose of the Offer and the Proposed Merger; Plans for DXL; Statutory Requirements; Approval of the Proposed Merger”)

 

(c) (1)-(7) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

INTRODUCTION

 

THE OFFER - Section 7 (“Possible Effects of the Offer on the Market for the Shares; Stock Exchange Listing; Registration Under the Exchange Act; Margin Regulations”)

 

THE OFFER - Section 11 (“Background of the Offer”)

 

THE OFFER - Section 13 (“Dividends and Distributions”)

 

Item 7. Source and Amount of Funds or Other Consideration.

 

(a), (b), (d) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

THE OFFER - Section 10 (“Source and Amount of Funds”)

 

THE OFFER - Section 17 (“Fees and Expenses”)

 

 

 

 

Item 8. Interest in Securities of the Subject Company.

 

(a), (b) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

THE OFFER - Section 9 (“Certain Information Concerning the Purchaser, Zodiac Partners II, LLC, and Camac Fund, LP”) and Schedule I attached thereto

 

THE OFFER - Section 11 (“Background of the Offer”)

 

Item 9. Persons/Assets, Retained, Employed, Compensated or Used.

 

(a) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

THE OFFER - Section 2 (“Acceptance for Payment and Payment for Shares”)

 

THE OFFER - Section 3 (“Procedure for Tendering Shares”)

 

THE OFFER - Section 11 (“Background of the Offer”)

 

THE OFFER - Section 17 (“Fees and Expenses”)

 

Item 10. Financial Statements.

 

(a) Not applicable.

 

(b) Not applicable.

 

Item 11. Additional Information.

 

(a) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

THE OFFER - Section 7 (“Possible Effects of the Offer on the Market for the Shares; Stock Exchange Listing; Registration Under the Exchange Act; Margin Regulations”)

 

THE OFFER - Section 11 (“Background of the Offer”)

 

THE OFFER - Section 12 (“Purpose of the Offer and the Proposed Merger; Plans for DXL; Statutory Requirements; Approval of the Proposed Merger”)

 

THE OFFER - Section 14 (“Conditions of the Offer”)

 

THE OFFER - Section 15 (“Certain Legal Matters; Regulatory Approvals; Appraisal Rights”)

 

(c) The information set forth in the Offer to Purchase and the Letter of Transmittal is incorporated herein by reference.

 

 

 

 

Item 12. Exhibits.

 

Exhibit Description
(a)(1)(A) Amended Offer to Purchase, dated June 23, 2026.*
(a)(1)(B) Amended Form of Letter of Transmittal.*
(a)(5)(A) Press Release Issued by Zodiac Partners II, LLC on May 12, 2026.
(d)    Equity Commitment Letter between Zodiac Partners II, LLC and Camac Fund LP, dated May 11, 2026.
(b)    Indicative $75 million Revolving Credit Facility Term Sheet (confidential treatment has been requested for certain portions of this exhibit).
107   Amended Filing Fee Exhibit.*
(a)(1)(C)   Amended Notice of Guaranteed Delivery.*
(e)   Schedule I.
(a)(1)(F)   W-9 Guidelines.
(a)(1)(E)   Amended Letter to Clients.*
(h)   Press Release Issued by Zodiac Partners II, LLC on May 21, 2026.
(j)   Press Release Issued by Zodiac Partners II, LLC on June 12, 2026.
(k)   Press Release Issued by Zodiac Partners II, LLC on June 23, 2026.*
(d)(2)   Amended Equity Commitment Letter between Zodiac Partners II, LLC and Camac Fund LP, dated June 22, 2026.*

 

* Asterisk describes exhibits filed herewith. No asterisk means the exhibit has been previously filed.

 

Item 13. Information Required by Schedule 13E-3.

 

Not applicable.

 

 

 

 

SIGNATURE

 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: June 23, 2026    
  Zodiac Partners II, LLC
   
  By: /s/ Ziggy Gokea
  Name: Ziggy Gokea
  Title: Managing Member
     
  Camac Fund, LP
   
  By: /s/ Eric Shahinian
  Name: Eric Shahinian
  Title: Manager of GP